Neogen Chemicals Falls 4.96%: 4 Key Factors Driving the Weekly Decline

09 February 2026: Gap Down Opening Reflects Market Concerns

Neogen Chemicals Ltd commenced the week with a pronounced gap down, opening 5.43% lower than the previous close at Rs.1,318.95. The stock touched an intraday low of Rs.1,281.05, closing the day at Rs.1,318.95, down 2.63%. This decline contrasted sharply with the Sensex, which gained 1.04% to close at 37,113.23. The gap down and subsequent price action underscored investor apprehension amid ongoing downward momentum, despite the stock trading above its short- and medium-term moving averages. The specialty chemicals sector, by comparison, showed resilience, gaining 2.46% on the day, highlighting company-specific challenges for Neogen Chemicals.

10 February 2026: Downgrade to Strong Sell Amid Weak Fundamentals

On 10 February, MarketsMOJO downgraded Neogen Chemicals from a 'Sell' to a 'Strong Sell' rating, citing deteriorating financials and bearish technical indicators. The downgrade followed the release of weak quarterly results and a worsening quality assessment. The company reported a modest average Return on Equity (ROE) of 9.65%, with operating profit growth over five years at a tepid 14.16% annually. Profit Before Tax (PBT) excluding other income plunged by 78.0% to Rs.3.26 crores, while net profit (PAT) declined 68.5% to Rs.3.37 crores. Return on Capital Employed (ROCE) dropped to 5.72%, signalling poor capital efficiency. Despite these challenges, the stock traded at a premium valuation with an Enterprise Value to Capital Employed ratio of 2.5 times, though it remained discounted relative to peers’ historical averages.

10 February 2026: Mixed Technical Signals Amid Bearish Momentum Shift

The stock closed at Rs.1,313.95 on 10 February, down 0.38%, continuing its downward trend. Technical indicators revealed a shift from sideways consolidation to a mildly bearish stance. Daily moving averages turned mildly bearish, with the stock slipping below key short-term averages. The weekly Moving Average Convergence Divergence (MACD) remained mildly bullish, but the monthly MACD turned bearish, signalling deteriorating longer-term momentum. The Relative Strength Index (RSI) was neutral weekly but bullish monthly, while the Know Sure Thing (KST) oscillator showed mixed signals: mildly bullish weekly but bearish monthly. Bollinger Bands suggested mild bullishness weekly but bearishness monthly. Volume-based On-Balance Volume (OBV) was neutral weekly but bullish monthly, indicating some accumulation despite price weakness. Overall, the technical picture was complex, with short-term optimism tempered by longer-term caution.

12 February 2026: Q3 FY26 Results Highlight Profit Collapse and Rising Interest Costs

Neogen Chemicals reported a sharp profit decline in its Q3 FY26 results, with Profit Before Tax excluding other income falling by 78.0% to Rs.3.26 crores and net profit dropping 68.5% to Rs.3.37 crores. The company faced surging interest costs, which exacerbated the profit erosion. Return on Capital Employed (ROCE) declined to 5.72%, reflecting poor capital utilisation. The financial trend showed weakening profitability and a high Debt to EBITDA ratio of 4.01 times, indicating significant leverage and potential liquidity risks. These results reinforced the bearish sentiment and contributed to the stock’s continued decline through the week.

Daily Price Performance vs Sensex

Key Takeaways

Negative Price Momentum: The stock declined 4.96% over the week, significantly underperforming the Sensex’s 0.54% fall, reflecting company-specific challenges amid broader market weakness.

Fundamental Weakness: The downgrade to Strong Sell was driven by deteriorating financial metrics, including a sharp profit collapse, low ROE of 9.65%, and high leverage with a Debt to EBITDA ratio of 4.01 times.

Technical Complexity: Mixed technical signals emerged, with short-term indicators turning bearish while some longer-term oscillators remained mildly bullish, indicating a cautious outlook with potential short-term rebounds but sustained downward pressure.

Quarterly Results Impact: The Q3 FY26 earnings revealed significant profit erosion and rising interest costs, reinforcing negative sentiment and contributing to the stock’s continued decline.

Conclusion

Neogen Chemicals Ltd’s performance during the week of 9 to 13 February 2026 was marked by a clear downward trajectory amid deteriorating fundamentals and mixed technical signals. The significant gap down opening and subsequent downgrade to a Strong Sell rating underscored heightened risks, while the quarterly results confirmed the company’s struggles with profitability and leverage. Despite some longer-term technical indicators suggesting mild bullishness, the prevailing sentiment remains cautious. Investors should note the stock’s underperformance relative to the Sensex and the specialty chemicals sector, alongside the company’s financial challenges, before considering any exposure. The week’s developments highlight the importance of closely monitoring both fundamental and technical factors in assessing Neogen Chemicals’ outlook.

Unlock special upgrade rates for a limited period. Start Saving Now →